title: Roche perspectives on Tamiflu.
authors.affiliation: Roche Products Ltd, Welwyn Garden City, UK. Electronic address: barry.clinch@roche.com.
authors.forename: B
authors.initials: B
authors.lastname: Clinch
authors.affiliation: F. Hoffmann-La Roche Ltd, Basel, Switzerland.
authors.forename: J
authors.initials: J
authors.lastname: Smith
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009980:Influenza A virus; D007251:Influenza, Human / Q000188:drug therapy* / Q000821:virology; D033181:Information Dissemination; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D053139:Oseltamivir / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D053139:Oseltamivir; D009439:Neuraminidase
keywords: Data sharing; Roche perspective; independent analysis; influenza; oseltamivir